Table 1.
Fatty acids | Relative abundance (%) ± SD |
---|---|
C12:0 | 0.1 ± 0.0 |
C14:0 | 1.5 ± 0.2 |
C15:0-iso | 0.0 ± 0.0 |
C15:0 | 0.2 ± 0.0 |
C16:0 | 23.0 ± 0.8 |
C16:1 Δ9 | 7.5 ± 0.3 |
C16:1 Δ11 | 0.1 ± 0.0 |
C16:2 Δ7.10 (n−6) | 0.3 ± 0.0 |
C16:3 Δ4,7,10 (n−6) | 0.6 ± 0.1 |
C17:1 | 0.1 ± 0.0 |
C16:3 Δ7,10,13 (n−3) | 0.6 ± 0.1 |
C16:4 Δ4,7,10,13 (n−3) | 11.1 ± 0.6 |
C18:0 | 13.9 ± 2.3 |
C18:1 Δ9 | 1.6 ± 0.1 |
C18:1 Δ11 | 3.6 ± 0.2 |
C18:2 Δ9,12 (n−6) | 2.3 ± 0.2 |
C18:3 Δ6,9,12 (n−6) | 1.0 ± 0.1 |
C18:3 Δ9,12,15 (n−3) | 19.4 ± 0.6 |
C18:4 Δ6,9,12,15 (n−3) | 3.2 ± 0.2 |
C20:0 | 0.2 ± 0.0 |
C20:4 Δ5,8,11,14 (n−6) | 1.1 ± 0.1 |
C20:5 Δ5,8,11,14,17 (n−3) | 8.9 ± 0.6 |
Σ SFA | 38.8 |
Σ MUFAs | 12.9 |
Σ PUFAs | 48.4 |
Σ (n−3) | 43.2 |
Σ (n−6) | 5.2 |
n−6/n−3 ratio | 0.1 |
AI | 0.5 |
TI | 0.3 |
(h/H) | 1.4 |
Values are expressed in relative abundance (%) and represent the mean of five analytical samples ± standard deviation (SD).
SFA saturated fatty acids, MUFAs monounsaturated fatty acids, PUFAs polyunsaturated fatty acids, AI atherosclerotic index, TI thrombogenic index, (h/H) (hypocholesterolemic/hypercholesterolemic) ratio.